International Society for Infectious Diseases

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (November 2018) (Learn how and when to remove this message) This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (November 2018) (Learn how and when to remove this message) (Learn how and when to remove this message)

International Society for Infectious Diseases

Abbreviation	ISID
Established	1986; 38 years ago (1986)
Merger of	International Congress on Infectious Diseases International Federation on Infectious and Parasitic Diseases.
Type	nonprofit
Purpose	Prevent, investigate, and manage infectious disease outbreaks when they occur.
Headquarters	9 Babcock St, Unit 3, Brookline, Massachusetts, US
Location	Massachusetts, US
Area served	Worldwide
Services	ProMED-mail
Field	infectious diseases
Official language	English
President	Paul Tambyah
Past-president	Alison Holmes
President-elect	Sally Roberts
Treasurer	Sally Roberts
Key people	Jaffar Al-Tawfiq Gonzalo Bearman Robert Heyderman Neelika Malavige Helena Maltezou Connie Walyaro
Publication	The International Journal of Infectious Diseases
Website	isid.org

The International Society for Infectious Diseases (ISID), established in 1986, is a nonprofit organization that monitors infectious diseases on a global scale. It also offers grants and fellowships, publishes a journal, and runs online learning platforms for sharing information on managing infectious diseases. It is based in Brookline, Massachusetts, US. The organization solicits donations from the general public, as well as governments, foundations, and the pharmaceutical industry.